XML 70 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-based Payment Award, Options Granted, Assumptions and Weighted Average Fair Value There were no options granted during the year ended December 31, 2021.
December 31,
202220212020
Weighted Average Fair Value of Grants$10.60 $— $3.56 
Risk-free Interest Rate3.02 %— %1.61 %
Expected Dividend Yield— %— %— %
Expected Forfeiture Rate— %— %— %
Expected Volatility54.00 %— %55.33 %
Expected Term in Years5.50— 5.11
Share-based Compensation, Stock and Performance Options Rollforward
A summary of the status of stock options granted is presented below:
Weighted
Average
WeightedRemainingAggregate
AverageContractualIntrinsic
ExerciseTerm (inValue (in
SharesPriceyears)thousands)
Outstanding at December 31, 20212,990,094 $12.72 
Granted10,850 $20.51 
Exercised(161,704)$7.15 
Forfeited(10,943)$10.53 
Expired(565,452)$31.17 
Outstanding at December 31, 20222,262,845 $8.55 3.68$18,792 
Exercisable at December 31, 20222,175,021 $8.43 3.54$18,302 
Schedule of Nonvested Restricted Stock Units Activity
The following table represents the nonvested restricted stock units and their corresponding fair value (based upon the closing share price) at the date of grant:
Number ofWeighted Average
SharesGrant Date Fair Value
Nonvested at December 31, 20212,037,977 $10.55
Granted1,134,980 $14.85
Vested(1,076,534)$10.94
Forfeited(262,503)$12.53
Nonvested at December 31, 20221,833,920 $12.69
Schedule of Nonvested Performance-based Units Activity
The following table represents the nonvested performance share units and their corresponding fair value (based upon the Monte Carlo Methodology for market-based awards and the stock price on the date of grant for performance based awards) on the date of grant:
Number ofWeighted Average
SharesGrant Date Fair Value
Nonvested at December 31, 20212,320,023 $11.20
Granted679,447 $11.37
Vested(72,353)$13.11
Forfeited(633,439)$13.60
Nonvested at December 31, 20222,293,678 $10.53